These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27163643)

  • 1. The glial cell modulator ibudilast attenuates neuroinflammation and enhances retinal ganglion cell viability in glaucoma through protein kinase A signaling.
    Cueva Vargas JL; Belforte N; Di Polo A
    Neurobiol Dis; 2016 Sep; 93():156-71. PubMed ID: 27163643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA/2J mouse model of glaucoma.
    Bosco A; Inman DM; Steele MR; Wu G; Soto I; Marsh-Armstrong N; Hubbard WC; Calkins DJ; Horner PJ; Vetter ML
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1437-46. PubMed ID: 18385061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of a JNK inhibitor against retinal ganglion cell loss induced by acute moderate ocular hypertension.
    Sun H; Wang Y; Pang IH; Shen J; Tang X; Li Y; Liu C; Li B
    Mol Vis; 2011 Apr; 17():864-75. PubMed ID: 21527996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy.
    Dapper JD; Crish SD; Pang IH; Calkins DJ
    Neurobiol Dis; 2013 Nov; 59():26-37. PubMed ID: 23859799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS axonal degeneration and transport deficits at the optic nerve head precede structural and functional loss of retinal ganglion cells in a mouse model of glaucoma.
    Maddineni P; Kasetti RB; Patel PD; Millar JC; Kiehlbauch C; Clark AF; Zode GS
    Mol Neurodegener; 2020 Aug; 15(1):48. PubMed ID: 32854767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH and NAC synergistically inhibits chronic ocular hypertension-induced neurodegeneration and neuroinflammation through regulating p38/MAPK pathway and peroxidation.
    Yu N; Wu X; Zhang C; Qin Q; Gu Y; Ke W; Liu X; Zhang Q; Liu Z; Chen M; Wang K
    Biomed Pharmacother; 2024 Jun; 175():116711. PubMed ID: 38735082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau Accumulation, Altered Phosphorylation, and Missorting Promote Neurodegeneration in Glaucoma.
    Chiasseu M; Cueva Vargas JL; Destroismaisons L; Vande Velde C; Leclerc N; Di Polo A
    J Neurosci; 2016 May; 36(21):5785-98. PubMed ID: 27225768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension.
    Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
    Brain Res; 2009 Dec; 1303():131-43. PubMed ID: 19765568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and activation of mitogen-activated protein kinases in the optic nerve head in a rat model of ocular hypertension.
    Mammone T; Chidlow G; Casson RJ; Wood JPM
    Mol Cell Neurosci; 2018 Apr; 88():270-291. PubMed ID: 29408550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway.
    Li Q; Cheng Y; Zhang S; Sun X; Wu J
    J Neuroinflammation; 2021 Nov; 18(1):271. PubMed ID: 34789280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.
    Madeira MH; Ortin-Martinez A; Nadal-Nícolas F; Ambrósio AF; Vidal-Sanz M; Agudo-Barriuso M; Santiago AR
    Sci Rep; 2016 Jun; 6():27532. PubMed ID: 27270337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated retinal glia mediated axon regeneration in experimental glaucoma.
    Lorber B; Guidi A; Fawcett JW; Martin KR
    Neurobiol Dis; 2012 Jan; 45(1):243-52. PubMed ID: 21867754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma.
    Bordone MP; González Fleitas MF; Pasquini LA; Bosco A; Sande PH; Rosenstein RE; Dorfman D
    J Neurochem; 2017 Jul; 142(2):323-337. PubMed ID: 28498493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of adenosine A
    Boia R; Salinas-Navarro M; Gallego-Ortega A; Galindo-Romero C; Aires ID; Agudo-Barriuso M; Ambrósio AF; Vidal-Sanz M; Santiago AR
    Cell Death Dis; 2020 May; 11(5):401. PubMed ID: 32461578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension.
    Kim ML; Sung KR; Kwon J; Choi GW; Shin JA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble Tumor Necrosis Factor Alpha Promotes Retinal Ganglion Cell Death in Glaucoma via Calcium-Permeable AMPA Receptor Activation.
    Cueva Vargas JL; Osswald IK; Unsain N; Aurousseau MR; Barker PA; Bowie D; Di Polo A
    J Neurosci; 2015 Sep; 35(35):12088-102. PubMed ID: 26338321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension.
    Wang X; Su J; Ding J; Han S; Ma W; Luo H; Hughes G; Meng Z; Yin Y; Wang Y; Li J
    Drug Des Devel Ther; 2016; 10():3449-3457. PubMed ID: 27799744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.
    Huang S; Huang P; Lin Z; Liu X; Xu X; Guo L; Shen X; Li C; Zhong Y
    Exp Eye Res; 2018 Mar; 168():33-48. PubMed ID: 29326065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.
    Reinhard J; Wiemann S; Joachim SC; Palmhof M; Woestmann J; Denecke B; Wang Y; Downey GP; Faissner A
    Mol Neurobiol; 2019 Jun; 56(6):4322-4345. PubMed ID: 30315478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.